This is in continuation of Company s letter no. NLL/CS/2025-545 dated August 26, 2025, vide which Notice of AGM has been informed to the exchanges. However, the page no. 3 has been missed out inadvertently in Notice of AGM. Please find attached revised notice of AGM.
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has refiled the notice for its 30th Annual General Meeting after page 3 was inadvertently missed in the original August 26 filing. The AGM will be held on September 29, 2025, at 11:00 AM IST via video conferencing, with the remote e-voting window open from September 26 (9:00 AM) to September 28 (5:00 PM) and September 22, 2025, as the cut-off date. Business to be transacted includes adoption of FY25 standalone and consolidated financial statements, re-appointment of Chairman & Managing Director Sanjiv Goyal (who retires by rotation and holds about 44.35% combined stake including HUF holdings), ratification of Cost Auditor V. Kumar & Associates' remuneration at INR 2 lakh per annum, appointment of Mr. Prince Chadha as Secretarial Auditor for five years (FY26-FY30) at INR 1 lakh per annum, and a special resolution to adopt new Articles of Association following Isengard Direct PE LLC's complete exit by December 11, 2024. Shareholders are reminded that unclaimed dividends for FY18 are due for transfer to IEPF on November 1, 2025.
Mostly procedural with no material surprise for shareholders. Investors should watch the September 29 AGM for approval of the director re-appointment and the new Articles of Association. Shareholders with unclaimed FY18 dividends should claim them before November 1, 2025, to avoid transfer to IEPF.